Clinical Trials on 化放疗 in China
总计165个结果
-
Anhui Shi, MDPeking University First Hospital; Xijing Hospital; Peking University People's Hospital; Sun Yat-sen... 和其他合作者完全的
-
Shanghai Zhongshan Hospital未知
-
Shanghai Changzheng HospitalThe First Affiliated Hospital of Nanchang University; Peking University People's Hospital; Sun... 和其他合作者招聘中
-
Peking University Cancer Hospital & Institute招聘中
-
Cancer Institute and Hospital, Chinese Academy...未知
-
Second Xiangya Hospital of Central South University招聘中
-
Daping Hospital and the Research Institute of Surgery...招聘中
-
Jun-Lin Yi, MD尚未招聘
-
Cancer Institute and Hospital, Chinese Academy...完全的The Optimal Sequence of Radiotherapy and Systematic Tyrosine Kinase Inhibitors in Treating Brain Metastases中国
-
Northern Jiangsu Province People's HospitalShanghai Junshi Bioscience Co., Ltd.招聘中
-
Zhongshan People's Hospital, Guangdong, ChinaSun Yat-sen University Cancer Centre招聘中
-
Sun Yat-sen UniversityFirst People's Hospital of Foshan; Cancer Research Institute of Zhongshan City主动,不招人
-
Second Affiliated Hospital, School of Medicine,...未知
-
Shanghai Chest HospitalFudan University; Shanghai Zhongshan Hospital; RenJi Hospital; Ruijin Hospital; Shanghai General Hospital... 和其他合作者未知
-
Shanghai Jiao Tong University Affiliated Sixth...招聘中
-
RenJi Hospital尚未招聘肝细胞癌 | 肝移植;并发症 | 肝癌 | 门静脉血栓形成 | 放射治疗;并发症中国
-
Fifth Affiliated Hospital, Sun Yat-Sen University招聘中鼻咽癌 | 卡培他滨 | 放疗 | PD-1抑制剂中国
-
Lei Li招聘中复发性宫颈癌 | 放疗 | 免疫疗法 | 生存结果 | 免疫检查点抑制剂 | 客观反应率 | 转移性宫颈癌 | 替雷利珠单抗 | 持续性宫颈癌 | 抗程序性细胞死亡受体 1中国
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
Second Affiliated Hospital, School of Medicine,...完全的
-
Tianjin Medical University Cancer Institute and...尚未招聘
-
Lei Li招聘中复发性宫颈癌 | 放疗 | 免疫检查点抑制剂 | 总生存期 | 抗程序性死亡-1 抗体 | 转移性宫颈癌 | 持续性晚期宫颈癌 | 客观缓解率 | 无进展生存期 | 严重不良事件中国
-
Nanfang Hospital, Southern Medical University招聘中
-
Sun Yat-sen University招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityMassachusetts General Hospital; Guangdong Provincial People's Hospital完全的
-
Sun Yat-sen University完全的放疗 | 信蒂利单抗 | 安罗替尼 | 自然杀伤/T 细胞淋巴瘤,鼻腔和鼻腔型 | 早期 | 聚乙二醇门冬酶 | 第二阶段 | 打开中国